DSM & Evonik to jointly set up $200-mn omega-3 fatty acids plant in US

Royal DSM and Evonik will jointly invest $ 200 million over the next two years to set up a manufacturing facility omega-3 fatty acid products from natural marine algae for animal nutrition in the US. This breakthrough innovation will, for the first time, enable the production of omega-3 fatty acids for animal nutrition without using fish oil from wild caught fish, a finite resource.

Two companies have agreed to form a joint venture (each holding a 50 percent share) for this purpose and co-own the production facility, which will be built at an existing site of Evonik and is expected to